Literature DB >> 22719396

2,6-Dichloro-7-isopropyl-7H-purine.

Nikola Hloušková, Michal Rouchal, Marek Nečas, Robert Vícha.   

Abstract

In the title mol-ecule, C(8)H(8)Cl(2)N(4), the essentially planar imidazole and pyrimidine rings [maximum deviations of 0.0030 (15) and 0.0111 (15) Å, respectively] make a dihedral angle of 1.32 (8)°. In the crystal, the fused-ring systems are stacked approximately parallel to the bc plane, with a centroid-centroid distance between inversion-related pyrimidine rings of 3.5189 (9) Å.

Entities:  

Year:  2012        PMID: 22719396      PMCID: PMC3379198          DOI: 10.1107/S160053681201879X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the synthesis, see: Oumata et al. (2008 ▶). For biological activity of some purine derivatives, see: Legraverend & Grierson (2006 ▶). For the selective synthesis of N7-substituted purines, see: Kotek et al. (2010 ▶). For related structures, see: Rouchal et al. (2009a ▶,b ▶, 2010 ▶).

Experimental

Crystal data

C8H8Cl2N4 M = 231.08 Triclinic, a = 7.0146 (5) Å b = 8.2862 (6) Å c = 8.9686 (7) Å α = 70.499 (7)° β = 83.820 (6)° γ = 74.204 (6)° V = 472.75 (7) Å3 Z = 2 Mo Kα radiation μ = 0.65 mm−1 T = 120 K 0.40 × 0.40 × 0.20 mm

Data collection

Oxford Diffraction Xcalibur Sapphire2 diffractometer Absorption correction: multi-scan (CrysAlis RED; Oxford Diffraction, 2009 ▶) T min = 0.933, T max = 1.000 2825 measured reflections 1656 independent reflections 1419 reflections with I > 2σ(I) R int = 0.011

Refinement

R[F 2 > 2σ(F 2)] = 0.023 wR(F 2) = 0.061 S = 1.05 1656 reflections 129 parameters H-atom parameters constrained Δρmax = 0.26 e Å−3 Δρmin = −0.24 e Å−3 Data collection: CrysAlis CCD (Oxford Diffraction, 2009 ▶); cell refinement: CrysAlis CCD; data reduction: CrysAlis RED (Oxford Diffraction, 2009 ▶); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 (Farrugia, 1997 ▶) and Mercury (Macrae et al., 2008 ▶); software used to prepare material for publication: SHELXL97. Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S160053681201879X/lh5458sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S160053681201879X/lh5458Isup2.hkl Supplementary material file. DOI: 10.1107/S160053681201879X/lh5458Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C8H8Cl2N4Z = 2
Mr = 231.08F(000) = 236
Triclinic, P1Dx = 1.623 Mg m3
Hall symbol: -P 1Melting point: 426 K
a = 7.0146 (5) ÅMo Kα radiation, λ = 0.71073 Å
b = 8.2862 (6) ÅCell parameters from 2034 reflections
c = 8.9686 (7) Åθ = 3.0–27.7°
α = 70.499 (7)°µ = 0.65 mm1
β = 83.820 (6)°T = 120 K
γ = 74.204 (6)°Block, colourless
V = 472.75 (7) Å30.40 × 0.40 × 0.20 mm
Oxford Diffraction Xcalibur Sapphire2 diffractometer1656 independent reflections
Radiation source: Enhance (Mo) X-ray Source1419 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.011
Detector resolution: 8.4353 pixels mm-1θmax = 25.0°, θmin = 3.5°
ω scanh = −8→8
Absorption correction: multi-scan (CrysAlis RED; Oxford Diffraction, 2009)k = −9→9
Tmin = 0.933, Tmax = 1.000l = −10→10
2825 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.023Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.061H-atom parameters constrained
S = 1.05w = 1/[σ2(Fo2) + (0.0323P)2 + 0.0416P] where P = (Fo2 + 2Fc2)/3
1656 reflections(Δ/σ)max < 0.001
129 parametersΔρmax = 0.26 e Å3
0 restraintsΔρmin = −0.24 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl10.22677 (6)0.42378 (6)−0.21906 (5)0.02126 (13)
Cl20.31193 (6)0.39565 (5)0.35468 (5)0.02020 (13)
N10.2261 (2)0.71202 (18)−0.16073 (15)0.0172 (3)
N20.26395 (19)0.44137 (17)0.05831 (15)0.0160 (3)
N30.27132 (19)0.83054 (17)0.17303 (15)0.0150 (3)
N40.2361 (2)0.96725 (18)−0.09060 (15)0.0175 (3)
C10.2390 (2)0.5421 (2)−0.09346 (19)0.0160 (4)
C20.2758 (2)0.5246 (2)0.15927 (18)0.0153 (4)
C30.2616 (2)0.7041 (2)0.10815 (18)0.0139 (3)
C40.2541 (2)0.9822 (2)0.04869 (19)0.0177 (4)
H40.25491.09140.06130.021*
C50.2397 (2)0.7924 (2)−0.05616 (18)0.0153 (4)
C60.2741 (2)0.8107 (2)0.34377 (18)0.0165 (4)
H60.36830.69520.39720.020*
C70.3474 (3)0.9569 (2)0.3651 (2)0.0245 (4)
H7A0.47650.95890.31150.037*
H7B0.36080.93580.47820.037*
H7C0.25251.07080.31950.037*
C80.0694 (2)0.8061 (2)0.41748 (19)0.0203 (4)
H8A−0.02530.91860.36700.030*
H8B0.07330.78790.53100.030*
H8C0.02820.70900.40200.030*
U11U22U33U12U13U23
Cl10.0217 (2)0.0247 (2)0.0217 (2)−0.00501 (18)−0.00236 (17)−0.01289 (18)
Cl20.0284 (3)0.0158 (2)0.0155 (2)−0.00685 (18)−0.00177 (17)−0.00235 (17)
N10.0152 (7)0.0196 (8)0.0164 (7)−0.0033 (6)−0.0005 (6)−0.0062 (6)
N20.0136 (7)0.0170 (8)0.0182 (7)−0.0040 (6)−0.0006 (6)−0.0064 (6)
N30.0158 (7)0.0140 (7)0.0155 (7)−0.0047 (6)−0.0004 (6)−0.0041 (6)
N40.0188 (8)0.0152 (8)0.0177 (7)−0.0045 (6)−0.0003 (6)−0.0038 (6)
C10.0109 (8)0.0211 (9)0.0188 (8)−0.0034 (7)0.0003 (7)−0.0105 (7)
C20.0109 (8)0.0182 (9)0.0152 (8)−0.0035 (7)0.0004 (6)−0.0036 (7)
C30.0094 (8)0.0166 (9)0.0162 (8)−0.0030 (7)0.0005 (6)−0.0062 (7)
C40.0161 (9)0.0137 (8)0.0220 (9)−0.0045 (7)−0.0003 (7)−0.0038 (7)
C50.0103 (8)0.0184 (9)0.0162 (8)−0.0030 (7)0.0005 (6)−0.0050 (7)
C60.0185 (9)0.0166 (9)0.0145 (8)−0.0036 (7)−0.0017 (7)−0.0053 (7)
C70.0301 (11)0.0255 (10)0.0230 (9)−0.0119 (8)−0.0007 (8)−0.0104 (8)
C80.0227 (10)0.0233 (10)0.0159 (8)−0.0066 (8)0.0016 (7)−0.0077 (7)
Cl1—C11.7437 (16)C3—C51.414 (2)
Cl2—C21.7249 (16)C4—H40.9500
N1—C11.315 (2)C6—C71.511 (2)
N1—C51.343 (2)C6—C81.519 (2)
N2—C21.3289 (19)C6—H61.0000
N2—C11.339 (2)C7—H7A0.9800
N3—C41.360 (2)C7—H7B0.9800
N3—C31.3770 (19)C7—H7C0.9800
N3—C61.486 (2)C8—H8A0.9800
N4—C41.318 (2)C8—H8B0.9800
N4—C51.371 (2)C8—H8C0.9800
C2—C31.381 (2)
C1—N1—C5112.46 (14)N4—C5—C3110.38 (14)
C2—N2—C1115.85 (14)N3—C6—C7110.35 (13)
C4—N3—C3105.08 (13)N3—C6—C8109.77 (12)
C4—N3—C6127.26 (14)C7—C6—C8112.12 (14)
C3—N3—C6127.25 (13)N3—C6—H6108.2
C4—N4—C5103.55 (13)C7—C6—H6108.2
N1—C1—N2130.38 (15)C8—C6—H6108.2
N1—C1—Cl1116.32 (12)C6—C7—H7A109.5
N2—C1—Cl1113.29 (12)C6—C7—H7B109.5
N2—C2—C3121.08 (14)H7A—C7—H7B109.5
N2—C2—Cl2116.30 (12)C6—C7—H7C109.5
C3—C2—Cl2122.62 (13)H7A—C7—H7C109.5
N3—C3—C2137.57 (15)H7B—C7—H7C109.5
N3—C3—C5105.65 (13)C6—C8—H8A109.5
C2—C3—C5116.70 (15)C6—C8—H8B109.5
N4—C4—N3115.34 (15)H8A—C8—H8B109.5
N4—C4—H4122.3C6—C8—H8C109.5
N3—C4—H4122.3H8A—C8—H8C109.5
N1—C5—N4126.13 (14)H8B—C8—H8C109.5
N1—C5—C3123.49 (15)
  7 in total

1.  Selective synthesis of 7-substituted purines via 7,8-dihydropurines.

Authors:  Vladislav Kotek; Naděžda Chudíková; Tomáš Tobrman; Dalimil Dvořák
Journal:  Org Lett       Date:  2010-11-19       Impact factor: 6.005

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 3.  The purines: potent and versatile small molecule inhibitors and modulators of key biological targets.

Authors:  Michel Legraverend; David S Grierson
Journal:  Bioorg Med Chem       Date:  2006-02-24       Impact factor: 3.641

4.  2-Chloro-9-isopropyl-N,N-dimethyl-9H-purin-6-amine.

Authors:  Michal Rouchal; Marek Nečas; Robert Vícha
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-02

5.  2-(1-Adamant-yl)-1-{4-[(2-chloro-9-isopropyl-9H-purin-6-yl)amino-meth-yl]phen-yl}ethanone.

Authors:  Michal Rouchal; Marek Nečas; Fabiana Pires de Carvalho; Robert Vícha
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-14

6.  Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1.

Authors:  Nassima Oumata; Karima Bettayeb; Yoan Ferandin; Luc Demange; Angela Lopez-Giral; Marie-Lorène Goddard; Vassilios Myrianthopoulos; Emmanuel Mikros; Marc Flajolet; Paul Greengard; Laurent Meijer; Hervé Galons
Journal:  J Med Chem       Date:  2008-08-13       Impact factor: 7.446

7.  (1-Adamant-yl){4-[(2-chloro-9-isopropyl-9H-purin-6-yl)aminometh-yl]phen-yl}methanone trichloro-methane solvate.

Authors:  Michal Rouchal; Marek Nečas; Robert Vícha
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-05-14
  7 in total
  1 in total

1.  Adamantane-Substituted Purines and Their β-Cyclodextrin Complexes: Synthesis and Biological Activity.

Authors:  Michal Rouchal; Jana Rudolfová; Vladimír Kryštof; Veronika Vojáčková; Richard Čmelík; Robert Vícha
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.